Physician profile
Jacob Spencer
NPI 1346565793
$9,740.90
in general payments reported to CMS, 2019-2025
26 companies · $399 in 2025
The $399 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,071 · 2020: $816 · 2021: $1,446 · 2022: $554 · 2023: $160 · 2024: $295 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team_makena_llc | $4,882.80 | 2019 | |
| Empire Medical, INC | $1,200.00 | 2021 | |
| Bioventus LLC | $579.79 | 2019-2024 | Exogen Ultrasound Bone Healing System, Durolane, Exogen Ultrasound Bone Healing System |
| Conformis, INC. | $520.12 | 2019-2022 | |
| Amgen INC. | $381.70 | 2021-2025 | Evenity, Prolia, Prolia |
| Horizon Therapeutics Plc | $327.26 | 2019-2022 | |
| Fidia Pharma USA INC. | $319.89 | 2019-2023 | Hymovis |
| Sportstek Medical, INC | $266.00 | 2019 | |
| Pacira Therapeutics, INC. | $198.54 | 2019-2020 | |
| Abbvie INC. | $196.48 | 2024-2025 | |
| Stryker Corporation | $164.88 | 2020 | |
| Novo Nordisk INC | $118.46 | 2024 | Wegovy |
| Linvatec Corporation | $112.61 | 2020 | |
| Zimmer Biomet Holdings, INC. | $108.67 | 2025 | Juggerknotless Soft Anchor |
| Ferring Pharmaceuticals INC. | $80.63 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $60.77 | 2019-2020 | |
| Encore Medical, Lp | $53.99 | 2022 | |
| Baudax Bio INC. | $29.61 | 2020-2021 | |
| Si-Bone, INC. | $23.43 | 2022 | |
| Heron Therapeutics, INC. | $21.18 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.31 | 2020 | |
| Sanofi-Aventis U.S. LLC | $18.68 | 2021 | |
| Convatec INC. | $17.82 | 2019 | |
| Depuy Synthes Sales INC. | $17.32 | 2019 | |
| Avanos Medical | $15.09 | 2019 | |
| Heraeus Medical, LLC. | $5.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Spencer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.